Skip to main navigation

Investor Relations

Investors & Media
Contact Us
Careers

Overview
News / Events
Company
Financial
Stock
SEC Filings
Governance

Overview
News / Events
Company
Financial
Stock
SEC Filings
Governance

Press Releases

Year

Feb 24, 2022

BioXcel Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022

Feb 22, 2022

BioXcel Therapeutics Announces Journal of the American Medical Association Publication of Data from SERENITY II Pivotal Phase 3 Trial Evaluating BXCL501 in Bipolar Disorders

Feb 14, 2022

BioXcel Therapeutics Presents Positive Data from Phase 2 Trial of BXCL701 in Aggressive Forms of Prostate Cancer at 2022 ASCO Genitourinary Cancers Symposium

Feb 09, 2022

BioXcel Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference

Jan 19, 2022

BioXcel Therapeutics Appoints Matt Wiley Chief Commercial Officer

Jan 04, 2022

BioXcel Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 16 of 16

Site - Investor Tools

Print Page

Tear Sheet

Email Alerts

RSS Feeds

Contacts

Search

About Us
Our Pipeline
Our Science
Patients & Advocacy

Investors & Media
Contact Us
Careers

Copyright © 2022 BioXcel Therapeutics, Inc. All Rights Reserved.

Privacy Policy
Disclaimer
Sitemap